The open benchmark competition will evaluate the ability of AI-powered virtual cell models to generalize to new cell contexts for therapeutic applications.

10x Genomics, Inc. (NASDAQ: TXG) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. It has announced a ...

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results , with sales up 9.8% year on year to $154.9 million. On the other hand, next quarter’s revenue guidance of $140 million was less ...

New single cell and spatial innovations extend 10x Genomics' technology and performanceleadership across all three platforms PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in ...

Advancing Large-Scale Single Cell Research. Building on a record year of Chromium product releases in 2024, 10x Genomics announced plans to enable high-performance, mega-scale single cell analysis ...

New single cell and spatial innovations extend 10x Genomics’ technology and performance Most Popular 1 County confirms “administrative error” for two Cannon Beach ballot measures 2 Ahead of ...

PLEASANTON, Calif., Feb. 23, 2025 /PRNewswire/ -- At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...

PLEASANTON, Calif., Oct. 15, 2024 /PRNewswire/ -- 10x Genomics, Inc. (TXG) (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the launch of two new Chromium products ...